FIELD: chemistry.
SUBSTANCE: invention provides novel pyrrolo[2,3-c]pyridine derivatives of formula 
(I), where radicals R1, R2, R3, R4 and R5 are as indicated in paragraph 1 of the formula of invention, or their pharmaceutically acceptable salts, as well as methods of producing the said compounds and a pharmaceutical composition having proton pump inhibiting effect.
EFFECT: novel compounds which exhibit excellent proton pump inhibiting effect and can have reversible proton pump inhibiting effect are obtained and described.
6 cl, 927 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND METHODS FOR MAKING THEREOF | 2005 |
|
RU2375359C2 |
| PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND METHOD OF PRODUCING SAID DERIVATIVES | 2005 |
|
RU2378275C2 |
| PYRROLO[3,2-b]PYRIDINE DERIVATIVES AND METHOD OF PRODUCING SAID DERIVATIVES | 2005 |
|
RU2397170C2 |
| NOVEL TETRAHYDROISOQUINOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION BASED THEREON, USE THEREOF AND METHOD OF TREATING AND/OR PREVENTING DISEASE | 2009 |
|
RU2474575C2 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2711502C2 |
| NOVEL PYRROLE COMPOUNDS, SYNTHESIS METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | 2014 |
|
RU2607788C2 |
| SUBSTITUTED PYRIMIDINETHIOALKYL OR ALKYLESTER COMPOUNDS AND METHOD OF INHIBITION OF VIRAL REVERSE TRANSCRIPTASE ACTIVITY | 1996 |
|
RU2167155C2 |
| ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF FOR INHIBITING NOREPINEPHRINE, DOPAMINE AND SEROTONIN REUPTAKE | 2005 |
|
RU2388751C2 |
| NEW PYRIDINE DERIVATIVES, METHOD FOR MAKING THEREOF AND RELATED PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2366659C2 |
| NOVEL PHOSPHATE COMPOUNDS, SYNTHESIS METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | 2014 |
|
RU2617682C2 |
